Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 1/2 1

Status

Unknown 4Recruiting 4Completed 3Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4

Conditions

Leukemia, Myeloid, Acute 33Myelodysplastic Syndromes 9Recurrence 7Hodgkin Disease 5Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Chronic 2Leukemia 2Wilms Tumor 1TP53 1Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden 1Primary Malignant Neoplasm of Ovary 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Blood Stem Cell Transplantation 1Pathologic Complete Response 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Malignant Solid Tumor 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid 1Hematopoietic System--Cancer 1Graft vs Host Disease 1Extranodal Extension 1Esophageal Squamous Cell Carcinoma 1

Interventions

Rituximab 55Cyclophosphamide 38Vincristine 25Prednisone 24Doxorubicin 21Cytarabine 18Etoposide 17Lenalidomide 16Gemcitabine 12Melphalan 8Filgrastim 8Cisplatin 8Peripheral Blood Stem Cell Transplantation 7Oxaliplatin 7N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7Methotrexate 7Ifosfamide 7Carmustine 7zanubrutinib 6R-CHOP protocol 6Vindesine 5Radiotherapy 5Dexamethasone 5Busulfan 5ibrutinib 4fludarabine phosphate 4Methylprednisolone 4Epirubicin 4Decitabine 4Cyclosporine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Lymphoma, Large B-Cell, Diffuse × Decitabine × Clear all
NCT05816746 2023-05-09

Decitabine and Anti-PD-1 in R/R DLBCL

Chinese PLA General Hospital

Phase 2 Unknown
20 enrolled
Lymphoid

Extranodal Extension, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT04025593 2020-11-19

Biomarker Guided Treatment in DLBCL

Ruijin Hospital

Phase 2 Unknown
128 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02951728 2020-03-11

DR-CHOP

Ruijin Hospital

Phase 1/2 Unknown
58 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT03579082 2018-09-14

A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma

Zhengzhou University

Phase 4 Unknown
60 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡